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SRCUpon ejaculation, spermatozoa undergo a series of post-translational modiﬁcations in a process known as
capacitation in order to prepare for fertilization. In the absence of capacitation, fertilization cannot occur.
Spermatozoa are unusual in that one of the hallmarks of capacitation is a global up-regulation in
phosphotyrosine expression, which is known to be mediated upstream by PKA. Little is known about the
signaling events downstream of PKA apart from the involvement of SRC, as a key mediator of PKA-induced
tyrosine phosphorylation in the sperm tail. Here we describe the presence of c-Abl in mouse spermatozoa. In
vitro analysis conﬁrmed that PKA can up-regulate c-Abl kinase activity. In vivo, this tyrosine kinase was found
to associate, and become threonine phosphorylated by PKA in the sperm ﬂagellum. By treating spermatozoa
with hemolysin we could demonstrate that a signiﬁcant proportion of the tyrosine phosphorylation
associated with capacitation could be suppressed by the c-Abl inhibitor, Gleevac. This is the ﬁrst report of c-
Abl being up-regulated by PKA for any cell type. We present a model, whereby these kinases may operate
together with SRC to ensure optimal levels of tyrosine phosphorylation in the sperm ﬂagellum during the
attainment of a capacitated state.© 2009 Elsevier Inc. All rights reserved.IntroductionEjaculated spermatozoa undergo a series of biochemical changes
and membrane remodeling events during their progression through
the female reproductive tract. These events bestow upon spermatozoa
the ability to bind to and fertilize the oocyte. Collectively, such
changes are known as “capacitation” (Chang, 1951). Initial reports
using radiolabelled methionine, thymidine or leucine as probes,
concluded that during capacitation, spermatozoa are transcriptionally
and translationally silent (Engel et al., 1973; Hernandez-Perez et al.,
1983). Recently, it has however been suggested that human, mouse,
rat and bovine spermatozoa may, in fact, produce small amounts of
proteins during capacitation through the mediation of mitochondrial
ribosomes (Gur and Breitbart, 2006). However, such reports have
been the topic of intense speculation (Boerke et al., 2007). Despite
this, it is well established that post-translational modiﬁcations are the
major means by which spermatozoa acquire full functionality
(Blaquier et al., 1988a,b; Ross et al., 1990; Baker et al., 2004, 2005).
Analysis of the post-translational modiﬁcations that occur in
capacitating mammalian spermatozoa has revealed a dramatic
increase in both the number, and level, of tyrosine phosphorylatedylethanolamine; SM, sphingo-
nces, The University of New-
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l rights reserved.proteins in response to protein kinase A (PKA) activation by cAMP
(Visconti et al., 1995; Baker et al., 2004; Bennetts et al., 2004). The
majority of these tyrosine phosphorylated proteins have been
localized to the sperm tail and appear to play an important role in
the physiological regulation of sperm movement. Thus, spermatozoa
originating from mice null for the sperm-speciﬁc PKA catalytic sub-
unit, possess forward progressive motility but are infertile (Nolan
et al., 2004). The infertility of these animals is associated with a failure
of capacitation, as reﬂected by their inability to express a speciﬁc form
of movement termed ‘hyperactivation’, which allows spermatozoa to
generate the propulsive forces necessary to penetrate the vestments
surrounding the oocyte (Amieux and McKnight, 2002; Nolan et al.,
2004). Signiﬁcantly, the lack of hyperactivated movement observed in
spermatozoa lacking functional PKAc was correlated with defective
tyrosine phosphorylation of the sperm tail (Nolan et al., 2004). This is
in keeping with studies demonstrating that both tyrosine phosphory-
lation and hyperactivation are inhibited upon addition of the PKA
inhibitor, H89 (Baker et al., 2004).
The regulation of PKA is clearly driven by changes in intracellular
cAMP, which, in turn, release the catalytic subunit of PKA from the
inhibitory inﬂuence of its regulatory subunits (Amieux and McKnight,
2002; White and Aitken, 1989). However, the identity of the inter-
mediate tyrosine kinase(s) that responds to PKA activation with the
widespread induction of tyrosine phosphorylation, is still incomple-
tely resolved. Available evidence suggests that a key player in this
signal transduction cascade is pp60c-src (SRC) (Baker et al., 2006).
This enzyme was found to be present within the mouse sperm ﬂa-
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tion occurs. Moreover, as cells became hyperactivated, autopho-
sphorylation on SRC could be detected in the sperm tail and this event
could be suppressed with the PKA inhibitor, H89 (Baker et al., 2006).
SRC was also found to co-immunoprecipitate with PKAc, but only
when spermatozoa were in the process of capacitation (Baker et al.,
2006). Such evidence clearly implicates SRC in the PKA-stimulated
activation of tyrosine kinase activity characteristic of capacitating
mammalian spermatozoa. However, it may not be the only kinase
involved (Lalancette et al., 2006). The complexity of the cAMP-
induced tyrosine phosphorylation response in terms of the subcellular
structures phosphorylated (ﬁbrous sheath, axoneme, mitochondrial
membranes) and the differential timing of these events, is consistent
with the involvement of more than one species of intermediate
tyrosine kinase (Nagdas et al., 2005; Petrunkina et al., 2003; Lin et al.,
2006). In light of these considerations, we have continued our search
for further tyrosine kinases involved in the regulation of sperm capa-
citation. The non-receptor tyrosine kinase c-Abl was the target for the
current investigation because this enzyme is inhibited by PP1 (Liu
et al., 1999, 2000; Tatton et al., 2003), a compound that is also known
to decrease the tyrosine phosphorylation and hyperactivation asso-
ciated with the attainment of a capacitated state.
Materials and methods
Chemicals
All chemicals were purchased from Sigma-Aldrich (Castle Hill,
NSW, Australia) at the highest research grade, with the exception of
albumin (Research Organics, Cleveland, OH, USA), D-glucose, sodium
hydrogen carbonate, sodium chloride, potassium chloride, calcium
chloride, potassium orthophosphate, and magnesium sulphide which
were all Analar grade and purchased fromMerck (BDHMerck, Kilsyth,
VIC, Australia). Tris was obtained from ICN Biochemicals (Castle Hill,
NSW, Australia) and acrylamide from Biorad (Castle Hill, NSW,
Australia). ABLtide and recombinant c-Abl were purchased from
Upstate Biotechnology (Lake Placid, NY). The goat anti-mouse anti-
body was obtained from Santa Cruz Biotechnology (Santa Cruz, CA)
and goat serumwas purchased from Hunter Antisera (Jesmond, NSW,
Australia). The molecular weight markers were from Fermentas
(Hanover, MD, USA). Radiolabelled 32γATP (2 mCi/ml; 370 mBq/ml;
3000 Ci/mmol) was from GE Healthcare (Castle Hill, NSW, Australia).
Recombinant PKAc was purchased from Calbiochem (San Diego, CA,
USA). An anti-phosphothreonine c-Abl speciﬁc monoclonal antibody
(an antibody that should only recognize the threonine phosphory-
lated form of Abl) was purchased from Cell Signalling Technology
(Danvers, MA), the anti-PKAc antibody was purchased from BD Bio-
sciences whilst a polyclonal anti-Abl antibody raised against a syn-
thetic peptide adjacent to the protein tyrosine kinase domain of
human c-Abl was purchased from Lab Vision (Clone 8E9). Gleevac
(STI-571) was a kind gift from Novartis.
Media
Biggers–Whitten–Whittingham medium (BWW) consisted of
95 mM NaCl, 44 μM sodium lactate, 25 mM NaHCO3, 20 mM HEPES,
5.6 mM D-glucose, 4.6 mM KCL, 1.7 mM CaCl2, 1.2 mM KH2PO4, 1.2 mM
MgSO4, 0.27 mM sodium pyruvate, 0.3% (w/v) BSA, 5 U/ml penicillin
and 5 μg/ml streptomycin, pH 7.4 (Biggers et al., 1971).
Preparation of mouse epididymal spermatozoa
Caudal epididymal spermatozoa were obtained from adult (8–
14 wk) Swiss mice. The experiments described in this report were
approved by the University of Newcastle Animal Ethics Committee.
The mice were euthanized by carbon dioxide asphyxiation and thereproductive tract was removed. Caudal spermatozoa were collected
by back-ﬂushing with water-saturated parafﬁn oil, collecting the
perfusate and depositing it directly into 1 ml of BWW at 37 °C. The
sperm suspensionwas left to disperse for 10 min at 37 °C and then the
sperm concentration was assessed using a Neubauer haemocyto-
meter. The cells were aliquoted into various treatments at a ﬁnal
concentration of 10×106 sperm/ml and then incubated at 37 °C under
an atmosphere of 5%CO2, 95% air. The spermatozoa were then induced
to capacitate by addition of 1 mM dbcAMP and 1 mM pentoxifylline
(PTX).
SDS-PAGE and Western blotting
SDS-PAGE was conducted on 1 μg solubilized sperm proteins
using 10% polyacrylamide gels at 10 mA constant current per gel. The
proteins were then transferred onto nitrocellulose hybond super-C
membrane (GE Healthcare) at 350 mA constant current for 1 h. The
membrane was blocked for 1 h at room temperature with Tris-
buffered saline (TBS; 0.02 M Tris, pH 7.6, 0.15 M NaCl) containing 3%
(w/v) BSA. The membrane was then incubated for 2 h at room
temperature in a 1:10,000 dilution of a monoclonal anti-phospho-
tyrosine (clone PY-66), anti-c-Abl (1/1000) or anti-phospho Abl
(1/2000) in TBS containing 1% (w/v) BSA and 0.1% (v/v) Tween 20.
After incubation, the membrane was washed 4 × for 5 min with TBS
containing 0.01% Tween-20. The anti-phospho c-Abl antibody was
then incubated for 1 h at room temperature with goat anti-rabbit
immunoglobin G horseradish peroxidase at a concentration of
1:3000 in TBS containing 1% (w/v) BSA and 0.1% (v/v) Tween-20.
The membrane was again washed as described above and phos-
phorylated proteins were detected using an enhanced chemilumi-
nescence (ECL) kit (GE Healthcare) according to the manufacturer's
instructions. In the case of PY-66, the direct peroxidase conjugate
allowed for visualization without the need for a labelled secondary
antibody.
Co-immunoprecipitation of c-Abl and PKA
Approximately 4 μg of anti-c-Abl antibody was added to 60 μl of
washed protein G DynaBead slurry and gently rocked for 1 h at 4 °C.
The protein G Dynabeads were isolated using a magnet to allow the
removal of the supernatant and subsequent washing of the beads
(2 ×). The spermatozoa were then lysed [1% (v/v) Triton X-100,
150 mM NaCl, 20 mM sodium orthovanadate, 20 mM Tris, protease
inhibitor tablet, pH 7.4] and 50–100 μg of the soluble lysate was added
to either protein G Dynabeads with conjugated antibody, or protein G
Dynabeads only, as a control for non-speciﬁc binding. The sample
was left to incubate overnight at 4 °C on a rotator (60 rpm) following
which, the slurry was washed twice (300 mM NaCl, 20 mM Tris,
pH 7.5) using the magnet as described above. Following com-
plete removal of the supernatant, the beads were resuspended in
2 × SDS lysis buffer. The sample was then boiled (5 min, 100 °C) prior
to SDS-PAGE.
Measurement of c-Abl and PKA interaction
In a ﬁnal volume of 20 μl of kinase reaction buffer (50 mM Tris, pH
7.4, 7.5 mM MgCl2, 1 mM EDTA, 2 mM sodium orthovanadate and
150 mM NaCl), 20 ng recombinant c-Abl was added to 0.1 ng
recombinant PKA. Inhibitors were introduced into the sample 10 min
prior to the addition of the ﬁnal substrate. To initiate the reaction, a
further 3 μl of a 2 mCi/ml stock solution of 32γATP (370 mBq/ml;
3000 Ci/mmol) was added. The samplewas left to incubate for 1.5 h at
37 °C, after which 1 volume of sample was added to equal volumes of
SDS-loading buffer and run on an 10% SDS-PAGE. The gel was
transferred onto nitrocellulose and autoradiography was performed
according to the manufacturer's instructions (PersonnalFX; BioRad).
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A 96 well ELISA plate was coated overnight with 5 μg of ABLtide at
37 °C, and washed 5 × with PBS containing 0.1% Tween (PBS-T). The
appropriate recombinant proteins and inhibitors were pre-incubated
for 10 min, after which the ﬁnal substrates were added and the entire
reaction stood for 45 min at 37 °C. Following the incubation period,
the samples were transferred to the ELISA plates and left for 5 min.
After this time had elapsed, the wells were washed 5 ×with PBS-T and
anti-phosphotyrosine was added for 30 min. The wells were again
washed 5 × with PBS-T and Sigmafast OPD (o-Phenylenediamine
dihydrochloride with phosphate-citrate buffer containing urea hydro-
gen peroxide) tablet was then added according to the manufacturer's
instructions. The reactionwas immediately stopped by addition of 2M
H2SO4. Detection of the phosphorylated peptide was then performed
using by measuring the OD at λ490 nm.
Hemolysin permeabilization
Hemolysin was a kind gift from Prof. Bhakdi, of the Institute of
Medical Microbiology and Hygiene, Hochhaus Augustusplatz, Mainz,
Germany; it contained a mutated cysteine that remained active
without the addition of DTT (Bhakdi et al., 1996). Following back-
ﬂushing of the spermatozoa, the cells were immediately placed in
BWW-BSA for 5 min at a concentration of 50×106/ml. Approximately
100 μl aliquots of this sample were diluted into 400 μl of BWW-BSA,
which contained either 1.25 μg/ml hemolysin, together with Gleevac
(10 μM ﬁnal), or the vehicle control for a further 10min. The cells were
then gently centrifuged (200 ×g, 2 min at 37 °C). The supernatant was
removed, and the media were replaced with complete BWW
containing 1 mM dbcAMP and 1 mM PTX or the vehicle. The uptake
of eosin dye was then immediately used to conﬁrm the permeabiliza-
tion of the spermatozoa.
Fluorescence microscopy
Images were obtained using a Zeiss Hal 100 ﬂuorescent micro-
scope incorporating a Zeiss axiovert stand (Ex λ488 nm, Em λ500–
530 mn).
Results
The presence and localization of c-Abl in mouse spermatozoa
Previous research indicating that PP1 cannot only inhibit sperm
hyperactivation but also the proto-oncogene, c-Abl (Liu et al., 1999,
2000; Tatton et al., 2003) prompted us to investigate the potential
role that this kinase might have in the control of sperm capacitation.
This study was initiated by testing for the presence of this enzyme in
mouse spermatozoa using a commercially available anti-c-Abl anti-
body. As illustrated in Fig. 1A, mature caudal epididymal spermatozoa
demonstrated a major band at 120 kDa, the expected size of c-Abl
(Fig. 1A) (Ponzetto and Wolgemuth, 1985). In order to localize the c-
Abl kinase in murine spermatozoa, we next performed immunocy-
tochemistry using the same anti-c-Abl antibody. As demonstrated in
Fig. 1B, a c-Abl signal was present in the tail and acrosome region of
both non-capacitated and capacitated spermatozoa. We did not
detect any change in the subcellular distribution throughout the
process of capacitation. For reference, a micrograph of the tyrosine
phosphorylation patterns seen in these sperm populations is also
shown (Fig. 1B).
Interaction between c-Abl and PKA
Since the tyrosine kinase(s) orchestrating the capacitation of
mouse spermatozoa are stimulated by a cAMP-dependent kinase(PKA), we sought to determine if PKA and c-Abl interacted and if so,
how this interaction affected enzyme activity. In order to achieve this,
anti-c-Abl antibody was used to immunoprecipitate the kinase and
other associated binding proteins from populations of capacitated
murine spermatozoa. Following elution and separation on an SDS-
PAGE gel, the sample was probed with an anti-PKAc antibody. A clear
band at 40 kDa, representing the catalytic subunit of PKA was present
(Fig. 1C, lane 2) but not in the pre-clear bead control, which had the
lysate passed over it (Fig. 1C, lane 1), indicating that this interaction
was not due to non-speciﬁc binding. Nor was this band identiﬁed in
the antibody only lane (Fig. 1C, lane 3). To conﬁrm this speciﬁcity, we
have also probed the same membrane using an antibody against heat
shock protein 70, an abundant protein in sperm lysates. We did not
observe this protein to be present in the c-Abl, pre-clear (and
obviously antibody only) lanes, suggesting that the interaction
between c-Abl and PKA is speciﬁc.
To further conﬁrm the interaction between c-Abl and PKA during
sperm capacitation, both recombinant proteins were purchased and
used for an in vitro enzyme-interaction assay, to determine the level of
cis- and trans-phosphorylation observed with this kinase mixture. To
ensure that PKA could phosphorylate c-Abl, this interaction was
measured with 32γATP, which allows transfer of the radiolabelled
phosphate group to a substrate. Addition of c-Abl only, together with
32γATP demonstrated a band of 120 kDa, representing the autopho-
sphorylation of kinase itself (Fig. 2B, lane 1). The addition of PKA up-
regulated the phosphorylation of c-Abl (Fig. 2B, lane 2), which could
be inhibited with 10 μM H89 (Fig. 2B, lane 4). As expected, 10 μM
Gleevac had no effect on the ability of PKA to phosphorylate c-Abl
(Fig. 2, lane 3). The silver stain of the recombinant proteins is given
(Fig. 2A), demonstrating that they are pure (N90%) preparations, and
that equal amounts of recombinant protein are present in each lane,
therefore the up-regulation of c-Abl phosphorylation is not due to
unequal protein loading. These data suggest, that in vitro, PKA can
phosphorylate c-Abl.
Activation of Abl kinase activity by PKA
Although, in vitro, PKA phosphorylates c-Abl, it was still unclear
what effect this would have on enzyme activity. Clearly, in vivo, c-Abl
does not change subcellular location during capacitation (Fig. 1B).
Therefore, we sought tomeasure changes to c-Abl enzyme activity. For
this cause, we performed a tyrosine kinase in vitro enzyme assay using
recombinant PKA and c-Abl proteins. Incubation with PKA alone did
not generate any signal on the “ABLtide” (the c-Abl-speciﬁc peptide
substrate, which only contains a tyrosine group for phosphorylation as
opposed to serine or threonine; Fig. 2C, lane 1 vs lane 2). The addition
of c-Abl alone signiﬁcantly increased the phosphorylated ABLtide
signal compared to the buffer control (P=0.001; Fig. 2C, lane 3). This
signal was sensitive to 10 μM Gleevac (lane 8), but not 10 μM H89
(lane 7). When both PKA and c-Abl were included, then c-Abl tyrosine
kinase activity was not only signiﬁcantly increased relative to the
buffer control (P=0.003) Fig. 2C, lane 1 vs lane 4), but also increased
compared to the c-Abl only treatment (P=0.03; Fig. 2C, lane 3 vs lane
4). This result clearly suggested that phosphorylation of c-Abl by PKA
increases the former's enzyme activity. Conﬁrming this interpretation,
when both PKA and c-Abl were incubated in the presence of H89 (Fig.
2C, lane 5), the signal dropped similar to that seen by c-Abl (lane 3)
only control. However, addition of 10 μM Gleevac (Fig. 2C, lane 6),
decreased the activity of c-Abl to background (lane 6 vs lane 1). These
data demonstrate, for the ﬁrst time, that PKA can phosphorylate c-Abl
and that a major consequence of this interaction is an up-regulation of
the enzyme's tyrosine kinase activity.
It is well recognized that many sites on proteins can be
phosphorylated leading to signiﬁcant changes in activity. In the case
of c-Abl, one known activation site is that of threonine 735, which
leads to increased enzyme activity. In order to see if this was the case
Fig. 1. Identiﬁcation and localization of c-Abl in mouse spermatozoa. (A) Spermatozoawere back-ﬂushed from the caudal region of the epididymis, lysed and run on a 10% SDS-PAGE.
Western blot analysis was performed as described inMaterials andmethods using the anti c-Abl antibody against 5 μg (lane 1) or 10 μg (lane 2) of lysate. Visualizationwas performed
using standard ECL chemiluminescence. The positions of the molecular mass markers are shown on the left hand side. (B) Non-capacitated and capacitatedmouse spermatozoa from
the cauda epididymis were ﬁxed, washed and subjected to immunocytochemistry as shown. The samples were then incubated with either anti-c-Abl (top panels), anti-
phosphotyrosine (middle panels) or the secondary antibody only controls (bottom panels: left, phase contrast; right, immunoﬂuorescence; Scale bar=50 μm). (C) Association of
c-Abl with PKA. Mouse sperm samples were capacitated, lysed and subjected to immunoprecipitation using the anti-c-Abl antibody as described in Materials and methods. The
immunoprecipitated lysates were run on a 10% SDS-PAGE and interrogated using the anti-PKAc antibody as described. Lane 1 is the pre-clear bead only control for non-speciﬁc
binding; lane 2 illustrates the immunoprecipitate obtained with the anti c-Abl antibody whilst lane 3 is the antibody only. Visualization was performed using enhanced
chemiluminescence according to the manufacturer's instructions. The arrow indicates the position of PKAc.
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the anti-phosphothreonine c-Abl antibody (anti-pThr-c-Abl; Fig. 2D).
As shown, a certain level of pThr735 was detected in the recombinant
proteinwithout PKAc (Fig. 2D, lane 1). However, this level did increaseupon addition of PKAc (Fig. 2D, lane 1 vs lane 2), although under our
assay conditions, this increase was only mildly sensitive to H89
treatment (lane 3). These data suggested that although phosphoryla-
tion of Thr735 may account for an increase in enzyme activity, it is
Fig. 2. Phosphorylation of c-Abl by PKA is inhibited with H89. (A) Recombinant c-Abl
(lanes 1–4) and recombinant PKAc (lanes 2–4) were added to the kinase reaction buffer
containing 32γATP as described Materials and methods. Prior to the addition of ATP,
10 μM H89 (lane 4) or 10 μM Gleevac (lane 3) were added to the reaction. A silver stain
demonstrating the purity of the proteins and relative amounts is given. (B) The amount
of transferred phosphate or autophosphorylation of c-ABL was visualized by
autoradiography as described in Materials and methods. (C) Tyrosine kinase activity
of phosphorylated and non-phosphorylated c-Abl. Recombinant PKA (lanes 2, 4–6) and
recombinant c-Abl (lanes 3–8) were incubated in the presence of kinase reaction buffer
mixture as described in Materials and methods. The buffer was immediately placed in
an ELISA plate, which contained ABLtide (a c-Abl peptide substrate). The addition of
10 μM H89 (lanes 5 and 7) or Gleevac (lanes 6 and 8) occurred before the addition of
either recombinant protein to the kinase reaction mixture. The amount of tyrosine
phosphorylated ABLtide was detected using anti-phosphotyrosine antibody according
to the manufacturer's instructions. Lane 1 represents the kinase reaction buffer only
(a, Pb0.05; b, Pb0.01; ANOVA using Fishers Protected Least Signiﬁcant Difference test).
(D) Recombinant c-Abl was incubated in the absence (lane 1) or presence (lanes 2
and 3) of PKAc as described inMaterials andmethods. Prior to the addition of ATP,10 μM
H89 (lane 3) were added. The samples were then run into SDS-PAGE, transferred and
probed with the anti-pThr-c-Abl antibody. The position on the molecular mass marker
is shown on the left hand side.
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tion to Thr735) play a role in up-regulating c-Abl.
Given the ability of Gleevac to suppress c-Abl kinase activity in
vitro, we next examined the impact of this competitive inhibitor on
the phosphorylation status and functional competence of intact cells.
Addition of increasing doses in Gleevac (0.1 to 100 μM), to mouse
spermatozoa had, to our surprise, no effect on the initiation of sperm
motility or the ability of cAMP to induce phosphotyrosine expression
or hyperactivation (data not shown). To further investigate the cause
for this apparent discrepancy, we looked for the presence of a
multispeciﬁc organic cation transporter channel in spermatozoa. In
order for cells to take up Gleevac, it has recently been demonstrated
that channels, including organic cation transporter 1 (Oct1) must be
present (Thomas et al., 2004). In the absence of this, and potentially
other cationic transporters (Hu et al., 2008), Gleevac is ineffective. Our
initial PCR screen of testicular mRNA demonstrated clearly the
presence of the Oct1 gene transcript (data not shown). In order to
localize this signal we performed in situ hybridisation on testicular
sections. The Oct1 signal clearly localized to the Leydig cells (data not
shown). The lack of a detectable Oct1 signal in the germ line may
explainwhy Gleevac has no effect on sperm function. To overcome this
problem, and examine the effect of Gleevac on tyrosine phosphoryla-
tion, we tried various sperm-permeabilization models, including
Triton X-100 and the pore-forming toxin streptetolysin O (SLO; data
not shown), as well as hemolysin derived from E. coli (Bhakdi et al.,
1996). The addition of either Triton X-100 or SLO completely disrupted
the tyrosine phosphorylation machinery in these cells. This is prob-
ably due to the complete removal of the plasmamembrane in the case
of Triton X-100 or the large pores formed by SLO (Bhakdi et al., 1996).
However, we were able to see an increase in tyrosine phosphorylation
expression, upon addition of dbcAMP, in hemolysin treated sperma-
tozoa (Fig. 3, lane 3 vs lane 4). This pattern was similar to that of theFig. 3. Suppression of tyrosine phosphorylation in spermatozoa treated with hemolysin.
The samples were run into SDS-PAGE, transferred to nitrocellulose and probed with
anti-phospho-tyrosine antibody or, following striping of the membrane, with anti-α-
tubulin to demonstrate equal protein loading as indicated. The following were loaded
into each lane: lane 1, non-capacitated spermatozoa without hemolysin treatment;
lane 2, capacitated spermatozoa incubated without hemolysin; lane 3 non-capacitated
spermatozoa incubated with hemolysin; lane 4, capacitated spermatozoa with hemo-
lysin treatment; lane 5, capacitated spermatozoa treated with hemolysin and 10 μM
Gleevac; lane 6, capacitated spermatozoa treated with hemolysin and 10 μM SU6656.
Phosphotyrosine expression and subsequent α-tubulin was then probed for accord-
ing to Materials and methods.
62 M.A. Baker et al. / Developmental Biology 333 (2009) 57–66positive control (lane 1 vs lane 2 — sperm not treated with hemo-
lysin). Addition of Gleevac to hemolysin treated sperm, in the
presence of dbcAMP demonstrated a signiﬁcant suppression of phos-
photyrosine expression (lane 4 vs lane 5) suggesting the involvement
of c-Abl in this cascade. The fact that this suppression was not
complete presumably reﬂects the important role that Src plays in
reinforcing the PKA-activated tyrosine phosphorylation in the sperm
tail during capacitation (Baker et al., 2006). To test this, we looked for
the ability of SU6656 to also decrease tyrosine phosphorylation.
Addition of this compound to hemolysin treated spermatozoa
inhibited this pathway (Fig. 3, lane 6). To demonstrate equal protein
load, the membrane was striped and re-probed with anti-α-tubulin
(Fig. 3B).
To demonstrate that the interaction between PKA and c-Abl was
not an in vitro artifact, we next looked to see whether an increase in
the level of pthr735 was occurring during capacitation in a H89-
dependent manner, using the anti-pThr-c-Abl antibody. As illustrated
in Fig. 4, an increase in c-Abl phosphothreonine levels could clearly
be detected during capacitation (Fig. 4B, lane 1 vs lane 2) in concert
with the concomitant increase in phosphotyrosine expression (Fig.
4A, lane 1 vs lane 2). This increase appeared to be induced by PKA,
since the PKA inhibitor, H89, dramatically reduced both c-Abl phos-
phothreonine (Fig. 4B, lane 3) and overall phosphotyrosine ex-
pression (Fig. 4A, lane 3). Equal protein loading across lanes was
demonstrated by reprobing the membrane with anti-c-Abl antibody
(Fig. 4C).
To explore further this apparent stimulation of c-Abl threonine
phosphorylation during capacitation by PKA, we next examined the
subcellular localization of the activated phosphothreonine-Abl signal
using immunoﬂuorescence. As illustrated, the signal originating from
c-Abl phosphothreonine expression was low in non-capacitatedFig. 4. Expression of phospho c-Abl increases during capacitation and is sensitive to H89
treatment. Mouse spermatozoa derived from the cauda epididymides were suspended
in BWW containing 1 mM dbcAMP and 1 mM pentoxifylline and immediately lysed
(non-capacitated, lane 1), incubated for 40min (capacitated, lane 2) or for 40min in the
additional presence of 10 μM H89 (capacitation suppressed, lane 3). The samples were
then run on a 10% SDS-PAGE and subject to (A) anti-phosphotyrosine Western blot
analysis (B) anti-phosphothreonine c-Abl or (C) anti-c-Abl antibody as described in
Materials and methods. The position of the molecular mass markers are shown on the
left hand side. Visualization was performed with enhanced chemiluminescence as
described by the manufacturer. Arrow indicates the internal loading control, cons-
titutively tyrosine phosphorylated sperm hexokinase.spermatozoa (Fig. 5, top right panel). However, following capacitation
the ﬂuorescence intensity changed to appear throughout the entire
ﬂagellum (Fig. 5, bottom left panel). Addition of H89 to capacitating
spermatozoa clearly decreased this level of c-Abl phosphothreonine
expression (Fig. 5, bottom right panel).
Discussion
A redox-regulated, cAMP-mediated tyrosine kinase cascade
involved in sperm capacitation was initially proposed several years
ago (Aitken et al., 1998; Lewis and Aitken, 2001; Visconti et al., 1995).
This system became up-regulated upon addition of either cAMP or
exposure to reactive oxygen species intermediates (Lewis and Aitken,
2001). Importantly, during capacitation, the levels of tyrosine
phosphorylation are clearly up-regulated in the ﬂagellum and, in
concert with this change, hyperactivated motility is expressed (Si and
Okuno, 1999). In all species studied to date, the tyrosine kinase(s) of
interest are clearly dependent on PKA. Thus, the sperm-speciﬁc
PKAαII knockout mouse is infertile, due to a complete absence of
hyperactivated motility (Nolan et al., 2004). Moreover, this knock-
out mouse showed no increase in phosphotyrosine expression
along the sperm tail under capacitating conditions, consistent with
the proposed central role for PKA in regulating this tyrosine kinase
cascade.
With these data in mind, the intermediate tyrosine kinase(s) that
are regulated by PKA and are responsible for the induction of
capacitation should also be localized along the length of the sperm
tail, from the neck to the tail end-piece, since this is the site of tyrosine
phosphorylation in capacitated cells. Although some reports have
focused on c-yes (Leclerc andGoupil, 2002),MAPK (Luconi et al.,1998)
and PI3K (Luconi et al., 2004) as potential redox-regulated enzymes
involved in this maturational event, this seems unlikely because these
particular kinases are conﬁned to the acrosomal domain ormidpiece of
the spermatozoa. Further to this, the activity of c-yes is insensitive to
herbimycin A (Fukazawa et al., 1991; Reinehr et al., 2004), which is a
compound that we have found to clearly reduce tyrosine phosphor-
ylation during sperm capacitation (Baker et al., 2006).
We have recently demonstrated another tyrosine kinase, namely
SRC, to be involved in the tyrosine phosphorylation events asso-
ciated with sperm capacitation. An interesting feature of this pro-
miscuous enzyme (Lee et al., 1995) is that it can be activated by
reactive oxygen species including hydrogen peroxide (Suzaki et al.,
2002). The fact that hydrogen peroxide is such a potent inducer of
tyrosine phosphorylation in capacitating mammalian spermatozoa,
underscores the potential importance of SRC as an intermediate tyro-
sine kinase involved in the control of sperm capacitation (Aitken et al.,
1995a,b; Rivlin et al., 2003). Furthermore, co-immunoprecipitation
studies demonstrated a clear association between SRC and PKA in
capacitated, but not uncapacitated, spermatozoa. This interaction
appeared to be physiological, since phospho-speciﬁc antibodies
directed towards an active form of SRC (Y416) demonstrated clearly
that capacitation was associated with an increase in this enzyme's
activity, via mechanisms that were sensitive to the PKA inhibitor, H89.
Together, these data suggest that following the cAMP rise observed
during sperm capacitation (White and Aitken, 1989) PKA binds to and
phosphorylates SRC, which undergoes an autophosphorylation-
mediated activation event. Furthermore, the fact that SRC is a pro-
miscuous enzyme and able to phosphorylate multiple sites and
multiple proteins, is consistent with the global increase of protein
tyrosine phosphorylation seen in capacitated spermatozoa. Another
dimension to this regulation is provided by the presence of C-
terminal SRC kinase (CSK) in the sperm ﬂagellum (Baker et al., 2006).
CSK itself is an inhibitor of the SRC-family of kinases. The mechanism
by which CSK achieves this suppression is through phosphorylation
of a tyrosine residue (Y529). However during capacitation, activa-
tion of PKA by cAMP leads to serine phosphorylation of CSK and
Fig. 5. c-Abl anti-phosphothreonine localization in capacitated and non-capacitated sperm. Fluorescence localization using the anti-phosphothreonine c-Abl antibody in non-
capacitated (upper right), capacitated spermatozoa (lower left) and capacitated sperm treated with 10 μMH89 (lower right), together with the secondary antibody only (upper left).
Original magniﬁcations: ×100. Scale bar=50 μm.
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but suppresses the physiological inhibitor of this kinase (Baker et al.,
2006).
In light of the foregoing, it is clear that SRC is a key regulator of
tyrosine phosphorylation in capacitating mammalian spermatozoa, as
recently conﬁrmed in human spermatozoa (Lawson et al., 2008;
Mitchell et al., 2008). However, the data generated in the present
study suggest that SRC does not act alone. This might have been
anticipated because ultrastructural analysis of this phosphorylation
event in murine spermatozoa has revealed a broad spectrum of
subcellular targets involving the mitochondria, ﬁbrous sheath and
plasma membrane. Furthermore, others have reported that tyrosine
phosphorylation in spermatozoa may occur via multiple pathways,
suggesting the involvement of more than one kinase in the control of
sperm capacitation (Nauc et al., 2004).
The ability of PP1, a recognized inhibitor of the tyrosine phos-
phorylation cascade associated with sperm capacitation (Baker et al.,
2006), to inhibit another tyrosine kinase, c-Abl (Liu et al., 1999, 2000;
Tatton et al., 2003) prompted an investigation of the role of this
enzyme during capacitation. Western blot analysis using anti-c-Abl
antibodies demonstrated the presence of a cross-reactive protein at
the expected size (∼120 kDa). Immunocytochemistry using the same
antibodies further supported a role for c-Abl in the regulation of
ﬂagellar activity, since the kinasewas clearly localized to this region of
the cell, as well as the acrosome. Interestingly, the presence of c-Abl
has been previously documented in human spermatozoa, using an
antibody raised against the tyrosine kinase domain of v-Abl although,
in this case, indirect immunoﬂuorescence located the enzyme to the
acrosome (Naz, 1998). Further, others have speculated that PKA may
interact with c-Abl during early spermatogenesis (Rawe et al., 2004).Our studies clearly demonstrate that in mouse spermatozoa, c-Abl is
located in both the acrosome and the sperm tail where it interacts
with PKA during capacitation.
Upon binding to c-Abl, PKA appears to threonine phosphorylate
this enzyme and up-regulate its kinase activity, although this may not
be the only mechanism by which PKA increases the activity of c-Abl.
Hence, others have shown that c-Abl is phosphorylated in three sites
during interphase and seven additional sites during mitosis (Kipreos
et al., 1987; Kipreos and Wang, 1988, 1990; Renshaw et al., 1992).
Furthermore, the physiological substrates for c-Abl-mediated phos-
phorylation in the sperm cell are not known at the present time.
Tyrosine phosphorylation of ﬁbrous sheath substrates such as AKAP3
(Luconi et al., 2005) and AKAP 4 (Turner et al., 1999) have previously
been reported and are thought to play a key role in the induction of
hyperactivated movement (Baker et al., 2006). A recent report of an
interaction between the SH3 domain of c-Abl and the N-terminal
region of phospholipid scramblase 1 (PS1) is also potentially signi-
ﬁcant in terms of the tyrosine phosphorylation of plasma membrane
proteins during capacitation (Sun et al., 2001). In the context of sperm
cell biology, a novel isoform of scramblase has been identiﬁed in
spermatozoa that is thought to be involved in the membrane
disordering events that accompany capacitation (Gadella and Harri-
son, 2000; Harrison and Gadella, 2005). This disordering activity
involves surface exposure of phosphatidylethanolamine, phosphati-
dylcholine and phosphatidylserine (PS) and can be detected extre-
mely early in capacitation, within 2 min of ejaculation (Gadella and
Harrison, 2000; Harrison and Gadella, 2005). Since the activation of
scramblase activity in spermatozoa is mediated by PKA (Gadella and
Harrison, 2000) the demonstration that c-Abl phosphorylates this
enzyme raises the possibility that this membrane disordering process
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PS is only expressed in the acrosomal region of capacitating sperm
cells. Thus, if indeed c-Abl is involved inmediating scramblase activity,
its activity is localized to a speciﬁc region of the cell.
In order to examine the functional signiﬁcance of c-Abl in the
control of tyrosine phosphorylation, a speciﬁc inhibitor is required
such as Gleevac (Imatinib) which works directly on the active site of
this enzyme (Hubbard, 2002). In our hands, addition of Gleevac, at
several doses, had absolutely no effect on motility activation, tyrosine
phosphorylation or hyperactivation. Subsequent investigation showed
that spermatozoa lack the required multispeciﬁc organic cation
transporter for this inhibitor to be taken up by the cell although it
cannot be ruled out that other cationic transporters may facilitate
Gleevac uptake (Hu et al., 2008). Furthermore, cell permeabilization
procedures including the use of Triton X-100 and SLO so disrupted the
spermatozoa's phosphorylation machinery that we were unable to
examine the inhibitory effects of Gleevac. Hemolysin, on the other
hand, is a toxin that forms small pores in the plasma membrane of
cells. With this permeabilization strategy, we were able to demon-
strate that spermatozoa maintained their ability to increase tyrosine
phosphorylation upon addition of dbcAMP. Under these conditions,
Gleevac clearly disrupted cAMP-induced tyrosine phosphorylation,
suggesting the involvement of c-Abl in the mediation of this signal
transduction cascade.Fig. 6. Amodel to explain the role of PKA inmediating sperm capacitation. During capacitatio
to the stimulation of sAC. This, is turn, leads to production of cAMP and downstream activatio
process such as hyperactivation, zona binding and possibly acrosomal exocytosis. PKA phosph
physiological inhibitor of this kinase, CSK, enhancing SRC activity still further. Furthermore, P
enhanced by activating tyrosine phosphorylations mediated by SRC. The fully activated c-SRC
tyrosine phosphorylated and drive the capacitation process forward with maximum efﬁcienBased upon the ﬁndings presented in this paper, and previous
work addressing the functional signiﬁcance of soluble adenylyl cyclase
(sAC) and the sperm-speciﬁc form of PKA in sperm cell biology (Nolan
et al., 2004), we can propose a model outlining our understanding of
the PKA-dependent tyrosine phosphorylation events occurring during
sperm capacitation. Following insemination, calcium enters the
spermatozoa and, in concert with bicarbonate and reactive oxygen
species activates sAC leading to the enhanced production of cAMP
(Aitken et al., 1995a,b; Lewis and Aitken, 2001; Breitbart, 2003; Rivlin
et al., 2003). It is possible however, that the combination of both
calcium (Zhao et al., 1992) and hydrogen peroxide (Hardwick and
Sefton,1995;Mukhopadhyay et al., 1995)may cause direct stimulation
of Src alone, leading to heightened tyrosine phosphorylation. Never-
theless, in our previous publication, it appears that Src activation is
dependent on the presence of PKA (Baker et al., 2006). As a result of
this increase in cAMP production, sperm-speciﬁc PKA becomes
activated through dissociation of the catalytic domain from its
regulatory subunits. PKA then appears to have a number of roles,
and could be considered the hub around which capacitation pathways
become activated. An early role for PKA appears to be the
phosphorylation-dependent suppression of CSK, allowing the sub-
sequent activation of SRC via another PKA-dependent phosphoryla-
tion event (Fig. 6; Baker et al., 2006). In this study we also present
evidence to suggest that PKA threonine phosphorylates c-Abl. This,n, a variety of factors including bicarbonate, reactive oxygen species and Ca2+ contribute
n of PKA. PKA is central to the induction of capacitation and events associated with this
orylates SRC in order to activate this tyrosine kinase and simultaneously inactivates the
KA phosphorylates c-Abl to activate this kinase. The activity of the latter may be further
and c-Abl kinases then co-operate to ensure that a number of key sperm targets become
cy.
65M.A. Baker et al. / Developmental Biology 333 (2009) 57–66and possibly other, as yet uncharacterized phosphorylation events,
lead to increased c-Abl tyrosine kinase activity. In concert these two
kinases, SRC and c-Abl, may orchestrate the dramatic increase in
tyrosine phosphorylation that characterizes the attainment of a
capacitated state (Fig. 6). The co-operation of SRC and c-Abl in
effecting the dramatic increase in phosphotyrosine expression that
accompanies capacitation is further reinforced by data indicating that
SRC can itself enhance the activation of c-Abl by stimulating activating
tyrosine phosphorylations on the activation loop of this kinase
(Plattner et al., 1999).
We have therefore added another dimension to the cellular
mechanisms regulating the tyrosine phosphorylation cascade asso-
ciated with sperm capacitation with the identiﬁcation of c-Abl as a
PKA-responsive tyrosine kinase involved in mediating the effects of
cAMP on sperm function. To our knowledge this is the ﬁrst time that
PKA has been implicated in the control of c-Abl for any cell type and in
this context these results make a signiﬁcant contribution to our
understanding of the fundamental mechanisms regulating the activity
of this kinase.
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